🏅 FDA Orphan Designation

Adagen

Pegademase bovine

Manufacturer: Sigma-tau Pharmaceuticals, Inc.

Indicated for:

Short-limb skeletal dysplasia with severe combined immunodeficiencyOrphan

FDA-Approved Indications (1)

Short-limb skeletal dysplasia with severe combined immunodeficiencyOrphan Designation

💙 Support Programs

View all →

Adagen

Sigma-tau Pharmaceuticals, Inc.

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.